Caregiver and Healthcare Professional Platforms Provide Resources for Initiating and Managing KYMBEE™ (deflazacort) Tablets Treatment
Maple Grove, MN – April 14, 2026 – Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW ... Read More
First Prescription Ear Drop Suspension Advances Portfolio Diversification Strategy
Maple Grove, MN – April 6, 2026 – Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX) today announced the recent ... Read More
Company Reinforces Commitment to Rare Disease Community through its Promise of Support® Program
Maple Grove, MN – December 1, 2025 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of KYMBEE™ (deflazacort) Tablets, indicated for the treatment ... Read More
From Epilepsy Awareness Day at Disneyland to the American Epilepsy Society Annual Meeting, the company continues its mission to improve understanding and care for people living with epilepsy and infantile spasms.
Maple Grove, MN – November ... Read More
Difluprednate Ophthalmic Emulsion 0.05%Upsher-Smith Laboratories, LLCNot actual size.
Maple Grove, MN – September 18, 2025 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Difluprednate Ophthalmic Emulsion 0.05%. According to IQVIA, the Difluprednate Ophthalmic ... Read More
UPSHER-SMITH AND PARENT COMPANY BORA PHARMACEUTICALS HOST IOWA GOVERNOR KIM REYNOLDS. Left to right: Jim Maahs, Head of Commercial, Upsher-Smith; Iowa Governor Kim Reynolds; Dennis Hall, Vice President and General Manager, Bora Pharmaceuticals.
Maple Grove, MN ... Read More
Visit Upsher-Smith at the PPMD 2025 Annual Conference Resource Fair to Learn More About Support Services and Resources Offered for Deflazacort Tablets
Maple Grove, MN – June 16, 2025 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced ... Read More
First and Only Ready-to-Use Vigabatrin Expands Treatment Access for Patients with Infantile Spasms
Maple Grove, MN – May 19, 2025 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that VIGAFYDE™ (vigabatrin) Oral Solution, the first and only ... Read More
Company to Feature First and Only Ready-to-Use Liquid Vigabatrin at Booth #846
Maple Grove, MN – April 4, 2025 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its participation at the 2025 American Academy of Neurology ... Read More
Maple Grove, MN – February 11, 2025 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are pleased to announce the recipients of the 2024 NASPA Excellence in Innovation Award. ... Read More
